Halozyme has completed its acquistion of Antares Pharma, creating a leading drug delivery business. View details here.
For InvestorsAntares Pharma: Making Medicines Feel Better

SEC Filings

Search By Keyword:
Filter By Year:
Filter By Type:
Showing 51 to 100 of 619
Date Title Type
2000-10-2010-K405/A [Amend] - Annual report [Sections 13 an10-K405/A
2000-10-20PRER14A - Preliminary Proxy Soliciting materialsPRER14A
2000-11-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2000-11-15425 - Prospectuses and communications, business c425
2000-12-18PRER14A - Preliminary Proxy Soliciting materialsPRER14A
2000-12-22PRER14A - Preliminary Proxy Soliciting materialsPRER14A
2000-12-28DEFM14A - Definitive proxy statement relating to DEFM14A
2001-02-158-K - Current report8-K
2001-02-27SC 13D - General statement of acquisition of beneSC 13D
2001-03-14SC 13G - Statement of acquisition of beneficial oSC 13G
2001-03-30NT 10-K - Notification of inability to timely filNT 10-K
2001-04-1610-K405 - Annual report [Sections 13 and 15(d), S10-K405
2001-04-178-K/A [Amend] - Current report8-K/A
2001-05-10DEF 14A - Other definitive proxy statementsDEF 14A
2001-05-14NT 10-Q - Notification of inability to timely filNT 10-Q
2001-05-2110-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2001-05-31S-3 - Registration statement under Securities ActS-3
2001-07-03S-8 - Securities to be offered to employees in emS-8
2001-08-14NT 10-Q - Notification of inability to timely filNT 10-Q
2001-08-1710-Q/A [Amend] - Quarterly report [Sections 13 or10-Q/A
2001-08-1710-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2001-11-0910-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2002-03-29NT 10-K - Notification of inability to timely filNT 10-K
2002-04-1510-K - Annual report [Section 13 and 15(d), not S10-K
2002-05-01PRE 14A - Other preliminary proxy statementsPRE 14A
2002-05-1310-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2002-05-14DEF 14A - Other definitive proxy statementsDEF 14A
2002-05-22ARS [Paper] - Annual Report to Security HoldersARS
2002-05-24SC 13D/A [Amend] - General statement of acquisitiSC 13D/A
2002-06-288-K - Current report8-K
2002-07-16PRE 14A - Other preliminary proxy statementsPRE 14A
2002-07-178-K - Current report8-K
2002-07-19S-3 - Registration statement under Securities ActS-3
2002-07-25REGDEX [Paper] - Notice of Sale of Securities [RegREGDEX
2002-07-26DEF 14A - Other definitive proxy statementsDEF 14A
2002-08-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2002-08-23S-3/A [Amend] - Registration statement under SecuS-3/A
2002-09-10S-3/A [Amend] - Registration statement under SecuS-3/A
2002-09-168-K - Current report8-K
2002-09-1910-Q/A [Amend] - Quarterly report [Sections 13 or10-Q/A
2002-09-1910-Q/A [Amend] - Quarterly report [Sections 13 or10-Q/A
2002-09-1910-K/A [Amend] - Annual report [Section 13 and 1510-K/A
2002-10-0910-K/A [Amend] - Annual report [Section 13 and 1510-K/A
2002-10-10424B3 - Prospectus [Rule 424(b)(3)]424B3
2002-10-10S-3/A [Amend] - Registration statement under SecuS-3/A
2002-11-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2002-11-19SC 13D/A [Amend] - General statement of acquisitiSC 13D/A
2002-12-038-K - Current report8-K
2003-02-11SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2003-02-128-K - Current report8-K
Showing 51 to 100 of 619